IBDEI0H9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8035,2)
 ;;=^335278
 ;;^UTILITY(U,$J,358.3,8036,0)
 ;;=787.24^^35^479^24
 ;;^UTILITY(U,$J,358.3,8036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8036,1,4,0)
 ;;=4^787.24
 ;;^UTILITY(U,$J,358.3,8036,1,5,0)
 ;;=5^Dysphagia,Pharyngoesoph
 ;;^UTILITY(U,$J,358.3,8036,2)
 ;;=^335279
 ;;^UTILITY(U,$J,358.3,8037,0)
 ;;=787.29^^35^479^20
 ;;^UTILITY(U,$J,358.3,8037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8037,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,8037,1,5,0)
 ;;=5^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,8037,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,8038,0)
 ;;=584.9^^35^480^2
 ;;^UTILITY(U,$J,358.3,8038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8038,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,8038,1,5,0)
 ;;=5^Acute Renal Failure
 ;;^UTILITY(U,$J,358.3,8038,2)
 ;;=^67114
 ;;^UTILITY(U,$J,358.3,8039,0)
 ;;=583.9^^35^480^19
 ;;^UTILITY(U,$J,358.3,8039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8039,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,8039,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,8039,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,8040,0)
 ;;=403.90^^35^480^51
 ;;^UTILITY(U,$J,358.3,8040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8040,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,8040,1,5,0)
 ;;=5^Renal Insufficiency with Hypertension (CRI and HTN)
 ;;^UTILITY(U,$J,358.3,8040,2)
 ;;=Renal Insufficiency with Hypertension (CRI and HTN)^269609
 ;;^UTILITY(U,$J,358.3,8041,0)
 ;;=593.9^^35^480^9
 ;;^UTILITY(U,$J,358.3,8041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8041,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,8041,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,8041,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;^UTILITY(U,$J,358.3,8042,0)
 ;;=581.9^^35^480^37
 ;;^UTILITY(U,$J,358.3,8042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8042,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,8042,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,8042,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,8043,0)
 ;;=753.12^^35^480^43
 ;;^UTILITY(U,$J,358.3,8043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8043,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,8043,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,8043,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,8044,0)
 ;;=791.0^^35^480^45
 ;;^UTILITY(U,$J,358.3,8044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8044,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,8044,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,8044,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,8045,0)
 ;;=791.9^^35^480^48
 ;;^UTILITY(U,$J,358.3,8045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8045,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,8045,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,8045,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,8046,0)
 ;;=592.0^^35^480^49
 ;;^UTILITY(U,$J,358.3,8046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8046,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,8046,1,5,0)
 ;;=5^Renal Calculi
 ;;^UTILITY(U,$J,358.3,8046,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,8047,0)
 ;;=403.91^^35^480^50
 ;;^UTILITY(U,$J,358.3,8047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8047,1,4,0)
 ;;=4^403.91
 ;;^UTILITY(U,$J,358.3,8047,1,5,0)
 ;;=5^Renal Failure, Chronic Hypertensive
 ;;^UTILITY(U,$J,358.3,8047,2)
 ;;=^269610
 ;;^UTILITY(U,$J,358.3,8048,0)
 ;;=586.^^35^480^53
 ;;^UTILITY(U,$J,358.3,8048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8048,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,8048,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,8048,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,8049,0)
 ;;=599.0^^35^480^65
 ;;^UTILITY(U,$J,358.3,8049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8049,1,4,0)
 ;;=4^599.0
 ;;
 ;;$END ROU IBDEI0H9
